spacer
home > ict > spring 2020 > managing trial data collection for success
PUBLICATIONS
International Clinical Trials

Managing Trial Data Collection for Success



Data collection has always been central to clinical research, but the breadth of information available today is truly unprecedented. It is not just that we have more data, it’s also that the data we are collecting are more complex. Clinical trial protocols have dramatically expanded the quantity and type of data being studied. New technologies, applications, and devices provide new information that has to be managed seamlessly.

Data collection must also keep pace with the fast-evolving world of clinical trial design. An example is the hybrid trial, which integrates a traditional randomised controlled trial with pragmatic design aspects to collect real-world patient outcome data. The nuances and complexities in this type of trial demand new approaches to data collection. Similarly, virtual trials are becoming increasingly important in a world where patients often live two hours or more from a testing site, and fear of contagion or inability to travel may preclude face-to-face meetings. To anticipate change and optimise success, companies must adapt, innovating new and flexible data collection methods. We must ensure data certainty with systems that are relevant, reliable, and precise.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author

Ed Seguine, CEO at Clinical Ink, is passionate about creating solutions for problems caused by current clinical trial processes and technologies. With more than 20 years of experience as a clinical technology executive at Big Pharma and startup organisations, Ed, a thought leader on key initiatives including CDISC and eClinical Forum, often presents at industry events and publishes regularly on the benefits of next-generation eSource solutions. He earned a Master of Business Administration from Indiana University- Bloomington, US, and a Bachelor of Science in Finance from Brigham Young University, US. eseguine@clinicalink.com
Print this page
Send to a friend
Privacy statement
News and Press Releases

ADM Supports Clinical Trial into Effects of Probiotic Supplements for COVID-19 Patients in Hospital Care

ADM and Hospital de Sagunto, one of the largest medical centers in the Valencia region, today announce their partnership for a clinical trial into the effects of using a food supplement containing live microbial strains to promote gut microbiome balance and help improve health functions related to outcomes for COVID-19 patients in high-risk groups. On 18th March Dr Xavier Cortés, gastroenterologist at Hospital de Sagunto, communicated with medical staff in China who had observed that many COVID-19 patients had exhibited abnormal changes in their gut microbiome.
More info >>

White Papers

Clinical Trial-Specific Travel Programs as a Patient Retention Tool

For many patients, participating in a clinical trial is a major endeavor. Depending on the protocol requirements, study visits can be exhausting. There are a number of reasons why a patient may choose to participate in a trial only to drop out. Conversely, there are several approaches to proactively try to prevent this from happening. There are various methods professionals implement for patient retention. This white paper explores patient travel services as one patient retention strategy.
More info >>

 
Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement